Features of COVID-19 and management of allergic rhinitis during the pandemic

  • Suzaki Isao
    Department of Otorhinolaryngology, School of Medicine, Showa University

Bibliographic Information

Other Title
  • 新型コロナウイルス感染症の特徴とパンデミックにおけるアレルギー性鼻炎への対応

Search this article

Description

<p>Coronavirus disease 2019 (COVID-19), a respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a worldwide pandemic in over 200 countries.</p><p>The nasal epithelium is enriched in angiotensin-converting enzyme 2 (ACE2) proteins, the key cell entry receptors for SARS-CoV-2, serve as the first barrier to protect the airway tract from viral infection. Recent studies have demonstrated detection of higher viral loads in the nasal cavity than in the pharynx of patients with COVID-19, and otolaryngologists should carefully consider the treatment of nasal conditions to prevent infection in clinical practice. Moreover, several studies have indicated that anosmia is one of the clinical characteristics of COVID-19, though its prevalence and mechanism remain unclear. Thus far, the comorbidity of allergic rhinitis does not seem to be a major risk factor for the severity of COVID-19. However, we should develop strategies in clinical practice for the treatment of nasal diseases such as allergic rhinitis during the pandemic.</p>

Journal

Details 詳細情報について

Report a problem

Back to top